BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24673184)

  • 1. Implementing two treatment approaches to childhood dysarthria.
    Levy ES
    Int J Speech Lang Pathol; 2014 Aug; 16(4):344-54. PubMed ID: 24673184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive treatment of dysarthria secondary to stroke.
    Mahler LA; Ramig LO
    Clin Linguist Phon; 2012 Aug; 26(8):681-94. PubMed ID: 22774928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive voice treatment (LSVT LOUD) for children with spastic cerebral palsy and dysarthria.
    Fox CM; Boliek CA
    J Speech Lang Hear Res; 2012 Jun; 55(3):930-45. PubMed ID: 22232407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on ataxic dysarthria: a case study.
    Sapir S; Spielman J; Ramig LO; Hinds SL; Countryman S; Fox C; Story B
    Am J Speech Lang Pathol; 2003 Nov; 12(4):387-99. PubMed ID: 14658991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings.
    Sapir S; Spielman JL; Ramig LO; Story BH; Fox C
    J Speech Lang Hear Res; 2007 Aug; 50(4):899-912. PubMed ID: 17675595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of an intensive voice treatment on articulatory function and speech intelligibility in children with motor speech disorders: A phase one study.
    Langlois C; Tucker BV; Sawatzky AN; Reed A; Boliek CA
    J Commun Disord; 2020; 86():106003. PubMed ID: 32505858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual and environmental contributions to treatment outcomes following a neuroplasticity-principled speech treatment (LSVT LOUD) in children with dysarthria secondary to cerebral palsy: a case study review.
    Boliek CA; Fox CM
    Int J Speech Lang Pathol; 2014 Aug; 16(4):372-85. PubMed ID: 25011399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of intensive voice treatment (LSVT LOUD
    Boliek CA; Fox CM
    Int J Speech Lang Pathol; 2017 Dec; 19(6):601-615. PubMed ID: 27705010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes to articulation following LSVT(R) and traditional dysarthria therapy in non-progressive dysarthria.
    Wenke RJ; Cornwell P; Theodoros DG
    Int J Speech Lang Pathol; 2010 Jun; 12(3):203-20. PubMed ID: 20433339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Lee Silverman Voice Treatment (LSVT) on hypernasality in non-progressive dysarthria: the need for further research.
    Wenke RJ; Theodoros D; Cornwell P
    Int J Lang Commun Disord; 2010; 45(1):31-46. PubMed ID: 19565392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing speech supplementation strategies: effects on intelligibility and speech rate of individuals with chronic severe dysarthria.
    Hustad KC; Jones T; Dailey S
    J Speech Lang Hear Res; 2003 Apr; 46(2):462-74. PubMed ID: 14700386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural Correlates of Hypokinetic Dysarthria and Mechanisms of Effective Voice Treatment in Parkinson Disease.
    Baumann A; Nebel A; Granert O; Giehl K; Wolff S; Schmidt W; Baasch C; Schmidt G; Witt K; Deuschl G; Hartwigsen G; Zeuner KE; van Eimeren T
    Neurorehabil Neural Repair; 2018 Dec; 32(12):1055-1066. PubMed ID: 30444176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The progress in the rehabilitation of dysarthria in Parkinson disease using LSVT (Lee Silverman Voice Treatment)].
    Kamińska I; Zebryk-Stopa A; Pruszewicz A; Dziubalska-Kołaczyk K; Połczyńska-Fiszer M; Pietrala D; Przedpelska-Ober E
    Otolaryngol Pol; 2007; 61(5):713-8. PubMed ID: 18552005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of speech and language therapy techniques for speech problems in Parkinson's disease.
    Herd CP; Tomlinson CL; Deane KH; Brady MC; Smith CH; Sackley CM; Clarke CE
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD002814. PubMed ID: 22895931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Lee Silverman Voice Treatment (LSVT®) speech therapy in progressive supranuclear palsy.
    Sale P; Castiglioni D; De Pandis MF; Torti M; Dall'armi V; Radicati FG; Stocchi F
    Eur J Phys Rehabil Med; 2015 Oct; 51(5):569-74. PubMed ID: 26138088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive voice treatment (the Lee Silverman Voice Treatment [LSVT
    Ertan E; Gürvit HI; Hanağası HH; Bilgiç B; Tunçer MA; Yılmaz C
    Logoped Phoniatr Vocol; 2022 Dec; 47(4):262-270. PubMed ID: 34287100
    [No Abstract]   [Full Text] [Related]  

  • 17. Acoustic changes in the speech of children with cerebral palsy following an intensive program of dysarthria therapy.
    Pennington L; Lombardo E; Steen N; Miller N
    Int J Lang Commun Disord; 2018 Jan; 53(1):182-195. PubMed ID: 28714530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innovative technology for the assisted delivery of intensive voice treatment (LSVT®LOUD) for Parkinson disease.
    Halpern AE; Ramig LO; Matos CE; Petska-Cable JA; Spielman JL; Pogoda JM; Gilley PM; Sapir S; Bennett JK; McFarland DH
    Am J Speech Lang Pathol; 2012 Nov; 21(4):354-67. PubMed ID: 23071195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive treatment of dysarthria in two adults with Down syndrome.
    Mahler LA; Jones HN
    Dev Neurorehabil; 2012; 15(1):44-53. PubMed ID: 22256834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved status following behavioural intervention in a case of severe dysarthria with stroke aetiology.
    Mackenzie C; Lowit A
    Int J Speech Lang Pathol; 2012 Aug; 14(4):318-28. PubMed ID: 22348261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.